Intended for healthcare professionals

  1. Research
  2. Efficacy and safety of...
  3. Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)
CCBYNC Open access
Research

Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.h6816 (Published 21 January 2016) Cite this as: BMJ 2016;352:h6816

Data supplement

Related articles

EditorialBetahistine for Meniere’s disease

See more

Cited by...

  • Interventions for Menieres disease: an umbrella systematic review
  • Effectiveness of endolymphatic duct blockage versus endolymphatic sac decompression in patients with intractable Menieres disease: study protocol for a double-blinded, randomised controlled trial
  • Sudden-onset dizziness and vertigo symptoms: assessment and management of vestibular causes
  • Long-term outcomes of triple semicircular canal plugging for the treatment of intractable Menieres disease: A single center experience of 361 cases
  • Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine
  • Treatment of vestibular disorders with weak asymmetric base-in prisms: An hypothesis with a focus on Menieres disease
Back to top